|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Interest-bearing deposits at financial institutions | ||||||||||||||||||||
| Securities held to maturity, at amortized cost, net of allowance for credit losses | ||||||||||||||||||||
| Securities held to maturity, at amortized cost (including securities pledged on other borrowings of $168,156 and $176,632, respectively, net of allowance for credit losses) | ||||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||||
| Securities trading, at fair value | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Loans receivable held for sale | ||||||||||||||||||||
| Loans/leases receivable held for investment | ||||||||||||||||||||
| Gross loans/leases receivable | ||||||||||||||||||||
| Less allowance for credit losses | ||||||||||||||||||||
| Net loans/leases receivable | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Restricted investment securities | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangibles | ||||||||||||||||||||
| Derivatives | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Junior subordinated debentures | ||||||||||||||||||||
| Derivatives | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Common stock, $1 par value; shares authorized 20,000,000 June 30, 2026 - 16,367,268 shares issued and outstanding December 31, 2025 - 16,690,603 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss: | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Derivatives | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
